CURE6d
PSMA-PET Improves Detection of Metastases in High-Risk Prostate Cancer
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...
Vietnam Investment Review on MSN10h
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Telix Pharmaceuticals Limited today announces that the United States Food and Drug Administration has approved its New Drug ...
Pharmabiz2d
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
Targeted Oncology6d
Overcoming Challenges in Adopting Epigenetic Liquid Biopsy for Prostate Cancer
Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.
GlobalData on MSN3d
Telix’s prostate cancer imaging agent approved in Brazil
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent. Illuccix claims to be the first prostate-specific membrane ...
American Association of Individual Investors2d
Which Is a Better Investment, Globus Medical, Inc. or Lantheus Holdings, Inc. Stock?
Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...
Up 113% in a year, guess which ASX 200 healthcare stock just scored another FDA win
The S&P/ASX 200 Index (ASX: XJO) healthcare stock is charging higher again on Friday following another FDA goal.
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, ...
Telix Pharmaceuticals Limited: Illuccix Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...